drugset / Trial / NCT02674204

STOP Heart Disease in Breast Cancer Survivors Trial

NCT02674204

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to to examine the effects of atorvastatin, a type of statin, on changes to the heart among women undergoing breast cancer treatment. Atorvastatin may reduce or eliminate the harmful effects of chemotherapy treatment to the heart tissue of breast cancer patients.

Timeline

Start
2016-05-05
Primary completion
2018-05-25
Completion
2018-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg Oral